Related Experiment Videos
An update on inflammatory myositis in children
1Division of Rheumatology, IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
Current Opinion in Rheumatology
|August 6, 2013
Summary
Recent research on juvenile idiopathic inflammatory myopathies (JIIMs) reveals environmental triggers and immune system abnormalities. While mortality is low, tissue damage is a concern, and new therapies are under investigation.
Area of Science:
- Rheumatology
- Pediatric Autoimmunity
- Immunology
Background:
- Juvenile idiopathic inflammatory myopathies (JIIMs) are rare rheumatic diseases in children.
- Understanding and treatment of JIIMs are continually evolving worldwide.
Purpose of the Study:
- To review significant recent contributions to the literature on JIIMs.
- To highlight advancements in understanding and potential therapies for childhood myositis.
Main Methods:
- Review of recent published literature on juvenile idiopathic inflammatory myopathies.
- Analysis of emerging findings in immunology, environmental triggers, and treatment modalities.
Main Results:
- Environmental factors are common in childhood myositis; cancer is rarely a cause.
- Newer research points to immune system aberrations, including type I interferons and myositis-specific antibodies.
- Tissue damage accumulation is a concern in juvenile dermatomyositis (JDM), despite low mortality.
- The role of biologic therapies is under investigation, and physical exercise is recognized as potentially beneficial.
Conclusions:
- International collaborative efforts are expanding the knowledge base of JIIMs.
- Ongoing research aims to improve understanding and therapeutic outcomes for children with myositis.
Related Concept Videos
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...